Patents by Inventor Bharat Joshi

Bharat Joshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11917033
    Abstract: Techniques discussed herein are directed to identifying health assessment data of a set of computing instances of a distributed computing system. The health assessment data may be collected from the computing instances and stored in a first distributed cache. When a request for health assessment data for one or more computing instances is received, the health assessment data may be retrieved from the first distributed cache, provided to the requesting entity, and stored in a second distributed cache. A subsequent request may cause new health assessment data to be retrieved from the first distributed cache and compared to the stored data of the second distributed cache. Changes in the health assessment data may be identified and data indicating those changes may be provided in response to the subsequent request. One or more remedial actions may be performed in response to the health assessment data obtained.
    Type: Grant
    Filed: August 19, 2022
    Date of Patent: February 27, 2024
    Assignee: Oracle International Corporation
    Inventors: Shreyas Vinayakumar, Banashankar Veerad, Aleks Seovic, Kanishka Sharad Joshi, Saurabh Agarwal, Jinsu Choi, Meghal Bharat Gosalia
  • Publication number: 20230335258
    Abstract: A platform providing methods and systems for prevention and/or treatment of a health condition (e.g., mental health condition and/or weight-related condition), where a method can include: simultaneously reducing severity symptoms of the health condition and comorbid conditions upon: receiving a set of samples from one or more subjects; receiving a biometric dataset from one or more subjects; receiving a lifestyle dataset from one or more subjects; returning a genomic single nucleotide polymorphism (SNP) profile and a baseline microbiome state upon processing the set of samples, the biometric dataset, and the lifestyle dataset with a set of transformation operations; generating personalized intervention plans for the one or more subjects upon processing the genomic SNP profile and the baseline microbiome state with a multi-omic model; and executing the personalized intervention plans for the one or more subjects.
    Type: Application
    Filed: April 12, 2023
    Publication date: October 19, 2023
    Inventors: Ranjan Sinha, Shreyas V. Kumbhare, Inti Pedroso, Bharat Joshi, Santosh K. Saravanan, Karthik M. Muthukumar, Daniel E. Almonacid
  • Patent number: 11288140
    Abstract: Described herein is a system method for point in time blob restore. In response to receipt of a request to restore a particular blob range to a particular point in time, read and/or write operations on the particular blob range requested to be restored are blocked. Blob(s) in the particular blob range which have changed since the particular point in time are determined based, at least in part, upon information stored in a change log and/or a deleted blob store. A determination is made as to whether the requested restore operation can be performed, for example, based upon a restoration policy. When it is determined that the requested restore operation can be performed, blob(s) determined to have changed since the particular point in time based, at least in part, upon information stored in the change log and/or the deleted blob store are restored.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: March 29, 2022
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Venkates Paramasivam Balakrishnan, Krishnan Varadarajan, Maneesh Sah, Sundar P. Subramani, Bitan Deb, Bharat Joshi, Malavika Arunmozhi
  • Patent number: 11052057
    Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: July 6, 2021
    Assignees: MESHABERASE, LLC, The United States of America, as Represented by the Secretary, Dept of Health and Human Services
    Inventors: Benjamin Rubin, Raj Puri, Bharat Joshi
  • Publication number: 20210103940
    Abstract: Data-driven operating model (DDOM) systems and techniques are described to manage implementation, access, and promotion of digital services by a service provider system. In one example, the DDOM system includes a data aggregation module, a journey manager module and a segment manager module. The data aggregation module supports a unified data architecture that is then leverage by the journey and segment manager modules to support matrixed journey stage and segmentation of a data lake to provide insights that are not possible by a human being alone, that are usable to manage implementation, access, and promotion of digital services by a service provider system.
    Type: Application
    Filed: November 18, 2019
    Publication date: April 8, 2021
    Applicant: Adobe Inc.
    Inventors: Robert Keith Giglio, Mark Andrew Picone, Maninder Singh Sawhney, Eric L. Cox, Ashley Elizabeth Wells, Nicholas James Woo, Vineet Bhalla, Brandon John Tatton, Amit Sethi, Simmi Kochhar Bhargava, Ryan John Stansfield, Sharad Narang, Samarpan Das, Krishna Kishore Veturi, Jagadeswarareddi Vaka, Brian Daniel Block, Purnaram Kodavatiganti, Thomason Nguyen, Dhrumil Bharat Joshi, Amarendra Reddy Duvvuru, Ashfaq Mohiuddin, Sumesh Kumar
  • Publication number: 20210064483
    Abstract: Described herein is a system method for point in time blob restore. In response to receipt of a request to restore a particular blob range to a particular point in time, read and/or write operations on the particular blob range requested to be restored are blocked. Blob(s) in the particular blob range which have changed since the particular point in time are determined based, at least in part, upon information stored in a change log and/or a deleted blob store. A determination is made as to whether the requested restore operation can be performed, for example, based upon a restoration policy. When it is determined that the requested restore operation can be performed, blob(s) determined to have changed since the particular point in time based, at least in part, upon information stored in the change log and/or the deleted blob store are restored.
    Type: Application
    Filed: November 14, 2019
    Publication date: March 4, 2021
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Venkates PARAMASIVAM BALAKRISHNAN, Krishnan VARADARAJAN, Maneesh SAH, Sundar P. SUBRAMANI, Bitan DEB, Bharat JOSHI, Malavika ARUNMOZHI
  • Publication number: 20200147010
    Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Application
    Filed: October 7, 2019
    Publication date: May 14, 2020
    Applicants: MESHABERASE, LLC, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
    Inventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI
  • Publication number: 20190142769
    Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Application
    Filed: January 10, 2019
    Publication date: May 16, 2019
    Applicants: MESHABERASE, LLC, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
    Inventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI
  • Publication number: 20180042870
    Abstract: The present disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or derivatives thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Application
    Filed: September 8, 2017
    Publication date: February 15, 2018
    Applicant: Meshaberase, LLC
    Inventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI
  • Patent number: 9849025
    Abstract: A clinical grid electrode system for seizure control through local cooling, mapping brain function and me provision of reversible functional ablation. The system includes a modular, scalable, cooling and sensing array composed of a plurality of cooling sensing elements. The system also includes a control system to which die cooling and sensing array is coupled for providing for control and monitoring of die cooling sensing elements making up the cooling and sensing array.
    Type: Grant
    Filed: September 7, 2013
    Date of Patent: December 26, 2017
    Assignees: YALE UNIVERSITY, THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE, ITN ENERGY SYSTEMS, INC
    Inventors: Hitten P Zaveri, Dennis D Spencer, Bharat Joshi, David M Binkley, Bruce Lanning, Mohan S Misra
  • Publication number: 20150223971
    Abstract: A clinical grid electrode system for seizure control through local cooling, mapping brain function and me provision of reversible functional ablation. The system includes a modular, scalable, cooling and sensing array composed of a plurality of cooling sensing elements. The system also includes a control system to which die cooling and sensing array is coupled for providing for control and monitoring of die cooling sensing elements making up the cooling and sensing array.
    Type: Application
    Filed: September 7, 2013
    Publication date: August 13, 2015
    Inventors: Hitten P. Zaveri, Dennis D. Spencer, Bharat Joshi, David M. Binkley, Bruce Lanning, Mohan S. Misra
  • Publication number: 20050214355
    Abstract: Sterically stabilized cationic liposomes (SSCL) encapsulating a K type oligodeoxynucleotide (ODN) including a CpG motif are disclosed. These SSCL encapuslating a K type ODN can be used to effectively deliver the ODN to a cell. A novel method is also disclosed for producing the SSCL encapsulating the K type ODN. Administration of the SSCL encapsulating a K type ODN and a chemotherapeutic agent, such as a chimeric molecule comprising a targeting molecule selected from the group consisting of an IL-13, and an anti-IL-13 receptor antibody; and an effector molecule selected from the group consisting of a Pseudomonas exotoxin, a Diphtheria toxin, and a radionuclide, can be used to dramatically reduce the growth of solid tumors.
    Type: Application
    Filed: July 30, 2002
    Publication date: September 29, 2005
    Inventors: Dennis Klinman, Ihsan Gursel, Ken Ishii, Koji Kawakami, Bharat Joshi, Raj Puri